PBE

NYSE_ARCAStock

Invesco Biotechnology & Genome ETF

$76.48-1.73 (-2.21%)

52-Week Range

$56.01

$85.73

Key Stats

Market Cap

256.3M

P/E Ratio

N/A

Dividend Yield

0.01%

Beta

1.07

Volume

7.3K

Avg Volume

7.5K

Performance

-6.97%

-6.08%

+9.45%

YTD

-7.55%

+17.77%

+22.46%

+0.50%

Price Chart

ETF Exposure

PBE is held by 1 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DALT	Anfield Capital Diversified Alternatives ETF	2.92%	25,850	$1.5M	$45.8M	2.92%

About PBE ETF Exposure

Invesco Biotechnology & Genome ETF (PBE) is held by 1 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 256.3M, PBE is a widely held institutional stock. The stock currently trades at $76.48 with a dividend yield of 0.01%. Investors can gain exposure to PBE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PBE, sorted by portfolio weight.